Litcius/Paper detail

Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib–hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis

Kohei Togami, Arisa Ogasawara, Sayo Irie, Kenji Iwata, Kotaro Yamaguchi, Hitoshi Tada, Sumio Chono

2022European Journal of Pharmaceutics and Biopharmaceutics18 citationsDOI

Topics & Concepts

NintedanibIdiopathic pulmonary fibrosisPharmacologyMedicineLungPulmonary fibrosisBleomycinPharmacokineticsPhospholipidosisPathologyChemistryInternal medicineChemotherapyBiochemistryMembranePhospholipidInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisInhalation and Respiratory Drug DeliveryPneumonia and Respiratory Infections
Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib–hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis | Litcius